Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1965 15
1966 21
1967 26
1968 29
1969 35
1970 20
1971 34
1972 27
1973 23
1974 35
1975 35
1976 30
1977 33
1978 28
1979 25
1980 27
1981 39
1982 38
1983 39
1984 46
1985 44
1986 45
1987 41
1988 46
1989 64
1990 55
1991 53
1992 52
1993 42
1994 47
1995 38
1996 54
1997 41
1998 34
1999 25
2000 32
2001 21
2002 27
2003 14
2004 18
2005 10
2006 12
2007 13
2008 11
2009 10
2010 11
2011 3
2012 5
2013 5
2014 4
2015 9
2016 5
2017 6
2018 5
2019 4
2020 2
2021 3
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

1,506 results

Results by year

Filters applied: . Clear all
Page 1
Viloxazine: a review of the literature.
Ban TA, McEvoy JP, Wilson WH. Ban TA, et al. Int Pharmacopsychiatry. 1980;15(2):118-23. doi: 10.1159/000468422. Int Pharmacopsychiatry. 1980. PMID: 7002831 Review.
In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which vil …
In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were i …
Panic disorder: long-term pharmacotherapy and discontinuation.
Rickels K, Schweizer E. Rickels K, et al. J Clin Psychopharmacol. 1998 Dec;18(6 Suppl 2):12S-18S. doi: 10.1097/00004714-199812001-00004. J Clin Psychopharmacol. 1998. PMID: 9872708 Review.
One hundred six PD patients were enrolled in a double-blind, 8-month, placebo-controlled trial of alprazolam and imipramine. In the 8-week short-term phase, daily dosages were titrated up to 10 mg/day of alprazolam and 250 mg/day of imipramine. ...In the 6-month mai …
One hundred six PD patients were enrolled in a double-blind, 8-month, placebo-controlled trial of alprazolam and imipramine. In the 8 …
Plasma concentration and clinical effect in imipramine treatment of childhood enuresis.
Jorgensen OS, Lober M, Christiansen J, Gram LF. Jorgensen OS, et al. Clin Pharmacokinet. 1980 Jul-Aug;5(4):386-93. doi: 10.2165/00003088-198005040-00006. Clin Pharmacokinet. 1980. PMID: 6994982 Clinical Trial.
After 1 week on placebo the children were given imipramine in a fixed dose of about 1 mg/kg for 3 weeks. The enuresis frequency decreased significantly from the placebo to the first week on imipramine, but then no further improvement was observed. There was a signif …
After 1 week on placebo the children were given imipramine in a fixed dose of about 1 mg/kg for 3 weeks. The enuresis frequency decre …
Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.
Shrivastava RK, Cohn C, Crowder J, Davidson J, Dunner D, Feighner J, Kiev A, Patrick R. Shrivastava RK, et al. J Clin Psychopharmacol. 1994 Oct;14(5):322-9. J Clin Psychopharmacol. 1994. PMID: 7806687 Clinical Trial.
We evaluated the long-term safety and clinical acceptability of venlafaxine and imipramine in a double-blind, parallel-group, comparative study. Two hundred ninety depressed outpatients were treated with venlafaxine, and an additional 91 received imipramine for as l …
We evaluated the long-term safety and clinical acceptability of venlafaxine and imipramine in a double-blind, parallel-group, compara …
Comparative clinical evaluation of lofepramine and imipramine. Psychiatric aspects.
d'Elia G, Borg S, Hermann L, Lundin G, Perris C, Raotma H, Román G, Siwers B. d'Elia G, et al. Acta Psychiatr Scand. 1977 Jan;55(1):10-20. doi: 10.1111/j.1600-0447.1977.tb00136.x. Acta Psychiatr Scand. 1977. PMID: 320827 Clinical Trial.
Lofepramine, an imipramine analogue, was compared with imipramine in a multicentre, double-blind clinical trial. ...The drug compliance was checked by plasma levels of desmethylimipramine in the imipramine group, parent compound, and "apparent" desmethylimipr …
Lofepramine, an imipramine analogue, was compared with imipramine in a multicentre, double-blind clinical trial. ...The drug c …
Contrasts in antidepressant medications.
Wittenborn JR. Wittenborn JR. Br J Clin Pharmacol. 1977;4Suppl 2(Suppl 2):153S-156S. doi: 10.1111/j.1365-2125.1977.tb05743.x. Br J Clin Pharmacol. 1977. PMID: 334218 Free PMC article. Clinical Trial.
1 Two studies are reviewed, one in depressed patients, the other in healthy volunteers. 2 The effect of nomifensine and imipramine on depressed out-patients has been studied in a controlled double-blind manner. ...These involved use of a self-rating scale and four observer …
1 Two studies are reviewed, one in depressed patients, the other in healthy volunteers. 2 The effect of nomifensine and imipramine on …
Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S, et al. Andersch S, et al. Acta Psychiatr Scand Suppl. 1991;365:18-27. doi: 10.1111/j.1600-0447.1991.tb03097.x. Acta Psychiatr Scand Suppl. 1991. PMID: 1862730 Clinical Trial.
The drugs were tapered for 4 or 8 weeks and the patients were followed up for 6 months. Compliance at 3 weeks was 95% for alprazolam, 83% for imipramine and 88% for placebo; at 8 weeks 95% for alprazolam, 73% for imipramine and 46% for placebo. ...Alprazolam had a m …
The drugs were tapered for 4 or 8 weeks and the patients were followed up for 6 months. Compliance at 3 weeks was 95% for alprazolam, 83% fo …
Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression.
Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E. Le Noury J, et al. Int J Risk Saf Med. 2016 Sep 17;28(3):143-61. doi: 10.3233/JRS-160728. Int J Risk Saf Med. 2016. PMID: 27662279 Free PMC article. Clinical Trial.
RESULTS: Of patients entering the continuation phase, 15 of 49 for paroxetine (31%), 12 of 39 for imipramine (31%) and 12 of 31 for placebo (39%) completed as responders. Across the study, 25 patients on paroxetine relapsed (41% of those showing an initial response), 15 on …
RESULTS: Of patients entering the continuation phase, 15 of 49 for paroxetine (31%), 12 of 39 for imipramine (31%) and 12 of 31 for p …
Comparison of verapamil, diltiazem, and labetalol on the bioavailability and metabolism of imipramine.
Hermann DJ, Krol TF, Dukes GE, Hussey EK, Danis M, Han YH, Powell JR, Hak LJ. Hermann DJ, et al. J Clin Pharmacol. 1992 Feb;32(2):176-83. doi: 10.1002/j.1552-4604.1992.tb03823.x. J Clin Pharmacol. 1992. PMID: 1613128 Clinical Trial.
Imipramine (100 mg) was administered orally on the morning of day 4 of each study period. ...Since these metabolic processes are dependent on the cytochrome P450IID6 isozyme, these data suggest that labetalol decreases the oral clearance of imipramine by inhibiting …
Imipramine (100 mg) was administered orally on the morning of day 4 of each study period. ...Since these metabolic processes are depe …
1,506 results